2007 JASN IMPACT FACTOR 7.111	HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP
advanced	CURRENT ISSUE	ARCHIVES	JASN Express	ONLINE SUBMISSION

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by OMRAN, H. Articles by HILDEBRANDT, F. Search for Related Content PubMed PubMed Citation Articles by OMRAN, H. Articles by HILDEBRANDT, F.

Human Adolescent Nephronophthisis: Gene Locus Synteny with Polycystic Kidney Disease in Pcy Mice

HEYMUT OMRAN^*, KARSTEN HÄFFNER^*, SUSE BURTH^*, CARMEN FERNANDEZ, BERNARDO FARGIER, AMINTA VILLAQUIRAN, HANS-GERD NOTHWANG, SUSANNE SCHNITTGER^§, HANS LEHRACH, DAVID WOO^||, MATTHIAS BRANDIS^*, RALF SUDBRAK and FRIEDHELM HILDEBRANDT^*

^* University Children's Hospital, Freiburg University, Freiburg, Germany
University Hospital Los Andes, Merida, Venezuela
Max-Planck Institute for Molecular Genetics, Berlin, Germany
^§ University Hospital Großhadern, Munich, Germany
^|| University of California, Los Angeles, California.

Correspondence to Dr. Heymut Omran, University Children's Hospital, Mathildenstrasse 1, 79106 Freiburg, Germany. Phone: 49-761-270-4301; Fax: 49-761-270-4533; E-mail: omran{at}kk1200.ukl.uni-freiburg.de

Abstract. In a large Venezuelan kindred, a new type of nephronophthisis was recently identified: Adolescent nephronophthisis (NPH3) is a late-onset recessive renal cystic disorder of the nephronophthisis/medullary cystic group of diseases causing end-stage renal disease at a median age of 19 yr. With the use of a homozygosity mapping strategy, the gene (NPHP3) was previously localized to chromosome 3q22 within a critical interval of 2.4 cM. In the current study, the NPHP3 genetic region was cloned and seven genes, eight expressed sequence-tagged sites, and seven microsatellites were physically localized within the critical disease interval. By human-mouse synteny analysis based on expressed genes, synteny between the human NPHP3 locus on chromosome 3q and the pcy locus on mouse chromosome 9 was clearly demonstrated, thus providing the first evidence of synteny between a human and a spontaneous murine renal cystic disease. By fluorescence in situ hybridization the chromosomal assignment of NPHP3 to chromosome 3q21-q22 was refined. Renal pathology in NPH3 was found to consist of tubular basement membranes changes, tubular atrophy and dilation, and sclerosing tubulointerstitial nephropathy. This pathology clearly resembled findings observed in the recessive pcy mouse model of late-onset polycystic kidney disease. In analogy to pcy, renal cyst development at the corticomedullary junction was found to be an early sign of the disease. Through cloning of the NPH3 critical region and mapping of expressed genes, synteny between human NPH3 and murine pcy was established, thus generating the hypothesis that both diseases are caused by recessive mutations of homologous genes.

This article has been cited by other articles:

				K. Reue and L. Vergnes Thematic review series: Systems Biology Approaches to Metabolic and Cardiovascular Disorders. Approaches to lipid metabolism gene identification and characterization in the postgenomic era J. Lipid Res., September 1, 2006; 47(9): 1891 - 1907. [Abstract] [Full Text] [PDF]

				C. A. Parsons, H. J. Mroczkowski, F. E.A. McGuigan, O. M.E. Albagha, S. Manolagas, D. M. Reid, S. H. Ralston, and R. J. S. Reis Interspecies synteny mapping identifies a quantitative trait locus for bone mineral density on human chromosome Xp22 Hum. Mol. Genet., November 1, 2005; 14(21): 3141 - 3148. [Abstract] [Full Text] [PDF]

				J. A. Tanner and G. A. Tanner Dietary Potassium Citrate Does Not Harm the pcy Mouse Experimental Biology and Medicine, January 1, 2005; 230(1): 57 - 60. [Abstract] [Full Text] [PDF]

				P. D. Wilson Polycystic Kidney Disease N. Engl. J. Med., January 8, 2004; 350(2): 151 - 164. [Full Text] [PDF]

				L. M. Guay-Woodford Murine models of polycystic kidney disease: molecular and therapeutic insights Am J Physiol Renal Physiol, December 1, 2003; 285(6): F1034 - F1049. [Abstract] [Full Text] [PDF]

				M.-T. Bihoreau, N. Megel, J. H. Brown, B. Kranzlin, L. Crombez, Y. Tychinskaya, J. Broxholme, S. Kratz, V. Bergmann, S. Hoffman, et al. Characterization of a major modifier locus for polycystic kidney disease (Modpkdr1) in the Han:SPRD(cy/+) rat in a region conserved with a mouse modifier locus for Alport syndrome Hum. Mol. Genet., September 1, 2002; 11(18): 2165 - 2173. [Abstract] [Full Text] [PDF]

				H. Omran, G. Sasmaz, K. Haffner, A. Volz, H. Olbrich, R. Melkaoui, E. Otto, T. F. Wienker, R. Korinthenberg, M. Brandis, et al. Identification of a Gene Locus for Senior-Loken Syndrome in the Region of the Nephronophthisis Type 3 Gene J. Am. Soc. Nephrol., January 1, 2002; 13(1): 75 - 79. [Abstract] [Full Text] [PDF]

				H. Omran, K. Haffner, S. Burth, S. Ala-Mello, C. Antignac, and F. Hildebrandt Evidence for further genetic heterogeneity in nephronophthisis Nephrol. Dial. Transplant., April 1, 2001; 16(4): 755 - 758. [Abstract] [Full Text] [PDF]

Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673